4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-25-000245
Director sold 2,750 shares at an average $81.06 ($222,903)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FOLETTA MARK G Director | 2025-08-15 | Sale 10b5-1 | −2,555 | $81.02 | $207,003 | 51,316 | I: show line 1 in the form |
| FOLETTA MARK G Director | 2025-08-15 | Sale 10b5-1 | −195 | $81.54 | $15,900 | 51,121 | I: show line 2 in the form |
| Open-market sales · 2,750 sh · avg $81.06 · $222,903 | |||||||
Loading xslF345X05/wk-form4_1755553988.xml…